Understand the source comparison
Tolerance to AHK-Cu Cycling: Protocol Comparison
Understanding how different administration schedules affect long-term response helps researchers design protocols that balance efficacy with sustainability. The following comparison synthesizes observational data from tissue repair models and dermatological re
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Understanding how different administration schedules affect long-term response helps researchers design protocols that balance efficacy with sustainability. The following comparison synthesizes observational data from tissue repair models and dermatological research applications.
- Continuous Daily
- Ongoing (no breaks)
- None
- Strong initial response weeks 1–3, plateau by week 4–6, diminishing returns beyond 6 weeks
- Not recommended. Biological saturation limits benefit after initial remodeling phase
- 5 Days On / 2 Days Off (4–6 Weeks)
- 5 consecutive days
- 2 days weekly, then 2–4 weeks after 4–6 week cycle
- Sustained fibroblast activity markers, consistent collagen synthesis across multiple cycles
- Recommended. Aligns with remodeling timelines and prevents copper ion saturation
- 4 Weeks On / 2 Weeks Off
- 4 weeks continuous
- 2 weeks between cycles
- Moderate plateau at week 3–4, response recovery during washout, consistent benefit across 3+ cycles
- Acceptable. Simpler schedule with adequate consolidation time
- 6 Weeks On / 4 Weeks Off
- 6 weeks continuous
- 4 weeks between cycles
- Similar plateau at week 4–5, extended washout allows full matrix consolidation
- Acceptable for longer-term studies where frequent cycling isn't practical
- The "5 on / 2 off" pattern with 4–6 week total cycles demonstrates the most consistent biomarker response across extended timelines. The intra-week breaks prevent chronic copper elevation while maintaining therapeutic copper ion availability during active matrix remodeling. The multi-week washout allows collagen crosslinking to consolidate, inflammatory signaling to fully resolve, and fibroblast populations to return to baseline responsiveness before the next active phase.